The comprehensive nonclinical safety testing program required to support clinical development and ultimate registration of a novel therapeutic involves years of work and several different types of studies. This type of program is an essential component of the pharmaceutical R&D process and represents a considerable financial investment to the innovator.

Proficient design and support of nonclinical safety testing programs requires a customized and integrative strategy that is relevant to the intended clinical indication and acceptable to global health authorities.

Paracelsus can help your organization successfully meet this challenge by offering a range of professional toxicology and related services.

In addition, collateral expertise in key areas such as veterinary pathology, pharmacology, safety pharmacology, pharmacokinetics, pharmaceutical services and regulatory affairs (strategic and operational) is also available through highly knowledgeable and experienced professionals providing discipline-specific expertise to Paracelsus clients.